Investor rights law firm Halper Sadeh LLC is investigating four companies for potential securities law violations and breaches of fiduciary duties related to their proposed mergers and acquisitions. The firm is seeking increased consideration for shareholders and additional disclosures regarding the transactions.

Monteverde & Associates PC, a class action securities firm, is investigating four proposed mergers: The Brand House Collective's sale to Bed Bath & Beyond, Avidity Biosciences' acquisition by Novartis for $72 per share, NorthWestern Energy Group's sale to Black Hills Corp, and Two Harbors Investment Corp's merger with UWM Holdings Corporation. The firm is seeking shareholders with concerns about these transactions ahead of upcoming shareholder votes.

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies involving mergers and acquisitions.

Novartis anticipates 5-6% annual sales growth from 2025-2030, raised peak sales projections for key drugs like Kisqali and Scemblix, and expects to maintain operating margins above 40% while planning significant U.S. infrastructure expansion.

Novartis reported Q3 2025 results with net sales rising 8% to $13.91 billion, driven by strong performance in key growth drugs like Kisqali and Kesimpta. The company reaffirmed its full-year guidance despite generic competition and announced a $12 billion acquisition of Avidity Biosciences.

Dyne Therapeutics stock surged over 41% after Novartis announced a $12 billion acquisition of Avidity Biosciences, a peer biotech company developing similar muscle disorder therapies using antibody-based treatments.

Novartis will acquire Avidity Biosciences for $12 billion, focusing on its neuroscience pipeline and RNA-targeting platform, with shareholders receiving $72 per share and early-stage cardiology programs being spun off into a separate public company.

U.S. stock futures rose ahead of a busy week with earnings reports from major tech companies and the Federal Reserve's interest rate decision. Key events include earnings from Microsoft, Alphabet, Meta, Apple, and Amazon, with potential market-moving implications.

Law firm investigating the sale of Avidity Biosciences to Novartis at $72.00 per share, questioning whether the transaction fairly represents shareholder interests.

Novartis announced plans to acquire Avidity Biosciences for $12 billion, strengthening its neuroscience pipeline with innovative RNA therapeutics targeting genetic neuromuscular diseases.

June closed on a high note for the stock market, with the S&P 500, tracked by the SPDR S&P 500 ETF Trust (NYSE:SPY), gaining 3.2%, despite significant disparities in sector and industry performances. The technology sector, as tracked by the Technology Select Sector SPDR Fund (NYSE:XLK), led the 11 S&P 500 sectors in performance last month, surging 7.7% and achieving its strongest monthly gain this year. In stark contrast, utilities lagged, with the Utilities Select Sector SPDR Fund (NYSE:XLU) dropping 6.3%, marking the worst month since September 2023. Top Performing Industry ETFs In June The iShares Expanded Tech-Software Sector ETF (NYSE:IGV) rallied 11.3% last month, topping the rankings among industry ETFs. Hot on its heels was the VanEck Semiconductor ETF (NYSE:SMH), which climbed 8.4%, showcasing strong momentum in the semiconductor sector. Since hitting its low ...Full story available on Benzinga.com

Initial data from an early-stage study shows that treatment with Avidity's (RNA) experimental therapy could address the underlying cause of a rare muscle-weakening condition.